Aducanumab, Keytruda and more—FiercePharmaAsia by Angus Liu Friday, March 22, 2019 Eisai's stock plummets at AD failure; Keytruda has much upside in China, analysts say; Korea Exchange is dragged into Samsung accounting probe.
FiercePharmaAsia—Dr. Reddy’s, CanSino and more by Angus Liu Friday, October 27, 2017 Dr. Reddy's recalls more meds in the U.S., while the EMA recanted its plant's GMP certificate; China approved a domestic Ebola vaccine.
China approves self-developed Ebola vaccine by Angus Liu Tuesday, October 24, 2017 China's FDA approved a domestically developed Ebola vaccine based on a different virus type from GSK's and Merck's shots.
